688 out of 814 (85%) scans labelled as Alzheimer’s disease and with amyloid measurements, 926 out of 1798 (52%) scans labelled as MCI, and 78 out of 3257 (2%) scans labelled as cognitively normal filled our amyloid and tau criteria to be included in the Alzheimer’s disease Continuum group. The gene discussed is MAPT; the disease is Alzheimer disease.